Sign in
4

Changes in Ownership

BOSTON SCIENTIFIC CORP Filed Acc 0001225208-21-015271

EVP Global Chief Med Officer sold 7,018 shares at $43.21 ($303,248)

From the SEC's structured data for this filing

Trades in this filing

Meredith Ian T · EVP Global Chief Med Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-12-28 Sale : show line 1 in the form −7,018 $43.21 $303,248 26,243 D
Open-market sales · 7,018 sh · avg $43.21 · $303,248
Loading xslF345X03/doc4.xml…